HRT Financial’s M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant MBAC.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,911
Closed -$769K 4259
2021
Q4
$769K Hold
74,911
﹤0.01% 1353
2021
Q3
$773K Hold
74,911
﹤0.01% 1543
2021
Q2
$756K Hold
74,911
0.01% 1352
2021
Q1
$743K Buy
+74,911
New +$747K 0.01% 1471

Other funds holding MBAC.U

HRT Financial's MBAC.U Position: Q1 2022 in Review

HRT Financial sold out of M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant (MBAC.U) in Q1 2022, closing a stake of 74,911 shares — an estimated $769K sold.

HRT Financial first reported a position in MBAC.U in Q1 2021 and held it in 4 quarters. The position peaked at $773K in Q3 2021. 5 funds tracked by Wall St. Rank hold MBAC.U as of Q1 2022.

  • HRT Financial reported no remaining M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
  • HRT Financial sold 74,911 M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant shares in Q1 2022, an estimated $769K.
  • HRT Financial first reported a position in M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant in Q1 2021 and held it in 4 quarters.
  • HRT Financial's M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant position peaked at $773K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.